AP
Annexin Pharmaceuticals Stock: price and insider trades · Sweden
ISIN SE0013748894SE·
No insider purchase over the last 90 days. The latest, by Nils Anders Haegerstrand, was filed 28 Feb 2020.
Annexin Pharmaceuticals: what insiders have been doing
Insider filings for Annexin Pharmaceuticals are scarce in the Finansinspektionen feed, the latest one published on 28 February 2020. This page will fill in as new trades are disclosed. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Insider Decl.
3
Thresholds
n/a
Buy Volume
€5,375
1 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 28 February 2020
Declarations3 total
- 45,500 shares@ SEK 1.25100.0% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-88be3f76aa234a428358Canonical exit: 26 May 2020 (T+90)
- 1,404,972 shares@ SEK 1.15100.0% of flowBTA (betald tecknad aktie)FI:csv-9ade041985a463c80c54
- 1,404,972 shares@ SEK 1.15100.0% of flowBTA (betald tecknad aktie)FI:csv-853692e2028d60d4e958
3 of 3 declarations
About Annexin Pharmaceuticals
Annexin Pharmaceuticals is a pharmaceutical company focused on developing treatments for inflammatory diseases and cardiovascular disorders. It is listed on the XSTO exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations